Key Takeaways The U.S. Food and Drug Administration has delayed full approval of Novavax's COVID vaccineThe agency says it needs more data before making a final decisionNovavax says its vaccine is ...

Christine Grady, the wife of Anthony Fauci who served as the head of the National Institutes of Health Clinical Centers' ...

As the Department of Health and Human Services grapples with the fallout of mass layoffs directed by Secretary Robert F.

More top vaccine regulators at the FDA have either left or been forced out, which could hobble the agency's ability to ...

The Trump administration's mass firings at the U.S. Food and Drug Administration have removed employees critical to reviewing ...

Moderna's mRNA technology gained rapid validation as sales of its covid vaccine soared in 2021 and 2022, but we think the firm has yet to secure a narrow economic moat around its business, largely due ...

(Reuters) -British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's ...

The US Food and Drug Administration was supposed to make a final decision about whether or not to approve Novavax's (NVAX) COVID-19 vaccine this week, but that deadline has passed with no clarity on ...

Amid a period of great upheaval at the agency, the FDA has missed its deadline to decide on approval for Novavax’s COVID-19 ...

Ex-vaccine regulator Peter Marks promoted "ineffective therapy that gave patients false hope, eroded trust in the regulatory ...

The health secretary’s indiscriminate layoffs will undermine his own priorities.

Novavax's COVID-19 vaccine received FDA Emergency Use Authorization, but full approval faces delays as regulators request more data beyond the April 1 deadline.